SMS Pharmaceuticals Ltd has informed BSE that the Board of Directors of the Company at its meeting held on August 13, 2016, have considered and approved the Draft Scheme of Arrangement between the Company and SMS Lifesciences India Limited and their respective shareholders and creditors u/s. 391 to 394 of the Companies Act, 1956 ['the Draft Scheme']. The Board of Directors of the Company have approved the following share entitlement ratio based on the recommendations of the Independent Valuers. 'One (1) fully paid up equity share of Rs. 10/- each of SMS Lifesciences India Limited (Resulting Company) shall he issued and allotted for every twenty eight (28) fully paid equity shares of Re. 1/- each held by the members of SMS Pharmaceuticals Limited (Demerged Company).' The Draft Scheme is subject to necessary statutory and regulatory approvals including the approvals of the High Court, Stock Exchanges, SEBI, the respective shareholders and lenders/creditors of each of the Companies involved in the Draft Scheme. The draft scheme will be filed with the Stock Exchanges as per the applicable provisions of regulation 37 of the SEBI [Listing obligations and disclosure requirements] Regulations, 2015 ('SEBI LODR'). SMS Pharmaceuticals Ltd has informed BSE that regarding the 'Scheme of Arrangement in nature of Demerger between SMS Pharmaceuticals Limited (Demerged Company) & SMS Lifesciences India Limited (Resulting Company).' (As per BSE Announcement dated on 17.08.2016) With reference to the earlier letters dated August 13, 2016 & August 16, 2016, SMS Pharmaceuticals Ltd has now informed BSE that by an order dated October 31, 2016, (Order received by the Company on November 15, 2016) the Hon'bale High Court for the state of Telangana and for the state of Andhra Pradesh at Hyderabad has appointed Mrs.H Sita Devi as Chairperson to convene the meeting of Equity Shareholders of the Company to be held on December 17, 2016 at 11.00 AM at Jubilee Hills International Centre, Jubilee Hills, Hyderabad for the approval of the Scheme of Arrangement between SMS Pharmaceuticals Limited and SMS Lifesciences India Limited and their respective shareholders and Creditors. Further, the Hon'ble High Court has also appointed Mrs.Ammaji Nettem as Chairperson to convene the meeting of Creditors of the Company to be held on December 17, 2016 at 3.00 PM at Jubilee Hills International Centre, Jubilee Hills, Hyderabad for the approval of the Scheme of Arrangement between SMS Pharmaceuticals Limited and SMS Lifesciences India Limited and their respective shareholders and Creditors. (As Per BSE Announcement Dated on 16.11.2016) SMS Pharmaceuticals Ltd has informed BSE regarding the details of Voting results of Postal Ballot, under Regulation 44(3) of SEBI (LODR) Regulations, 2015 along with Scrutinizer's Report. SMS Pharmaceuticals Ltd has submitted to BSE a Copy of the Result of Postal Ballot. (As per BSE Announcement dated on 18.12.2016) Intimation of effective date of Scheme of Arrangement (As Per BSE Announcement Dated on 18.05.2017) Trading Members of the Exchange are hereby informed that, pursuant to the Scheme of Arrangement (Demerger) approved by the Hon'ble National Company Law Tribunal, Hyderabad Bench, SMS Pharmaceuticals Ltd., has fixed the Record Date for the purpose of determining entitlement of the shareholders of the Company, as per details given below: COMPANY NAME CODE SMS Pharmaceuticals Ltd. (532815) RECORD DATE 23/06/2017 PURPOSE As per Scheme of Arrangement sanctioned by the Hon'ble National Company Law Tribunal, Hyderabad Bench, between, SMS Pharmaceuticals Ltd and M/s SMS Lifesciences India Limited (Resulting Company) And Their Respective Shareholders And Creditors: - Upon the coming into effect of the aforesaid Scheme and in consideration of the demerger of Semi Regulated Units No. I, IV and V along with the premises situated at Industrial Estate , Santhnagar, Hyderabad and Investments relating to Semi Regulated Units of SMS Pharmaceuticals Ltd into SMS Lifesciences India Limited pursuant to this Scheme : SMS Lifesciences India Limited shall issue and allot equity shares at par on a proportionate basis to the shareholders of SMS Pharmaceuticals Ltd in the following proportion : '1 (ONE) fully paid up equity share of SMS Lifesciences India Limited shall be issued and allotted for every 28 (TWENTY EIGHT) fully paid up equity shares each held in SMS Pharmaceuticals Ltd.' EX-ENTITLEMENT FROM DATE & SETT. NO. 22/06/2017 DR-058/2017- 2018 Note: Pursuant to SEBI Circular No. SEBI/Cir/ISD/1/2010 dated September 2, 2010, Trading members are hereby informed that the trading in the equity shares of the aforesaid company shall be transferred from B' group to T' group w.e.f. June 22, 2017 and pursuant to SEBI Circular No. CIR/MRD/DP/01/2012 dated January 20, 2012; the aforesaid scrip shall be a part of Call Auction in Pre-open Session on June 22, 2017. Subject to compliance with requisite formalities the resulting company SMS Lifesciences India Limited will be listed on BSE Limited. (As Per BSE Notice Dated on 13.06.2017) Fixation of Record Date For The Purpose of Determination of Entitlement For Allotment Equity Shares as Per approved Scheme of Arrangement between M/s. SMS Pharmaceuticals Limited (Demerged Company) and M/s SMS Lifesciences India Limited (Resulting Company) and their respective Shareholders and Creditors. (As Per BSE Announcement Dated on 12.06.2017) Allotment of shares by SMS Lifesciences India Limited (Resulting Company) (As Per BSE Announcement Dated on 27.06.2017) Intimation of Resignation of Chief Financial Officer of the Company (As Per BSE Announcement Dated on 01.07.2017) Listing and admission of equity shares of SMS Lifesciences India Limited, on BSE& NSE. (As Per BSE Announcement Dated on 14.08.2017)